semaglutide for obesity What's New in Treatment? Semaglutide for Weight Loss: A

While first-line antihyperglycemic agentsincluding metformin, sulfonylureas, and exogenous insulinachieve robust glycemic control, their chronic administration is frequently constrained by dose-dependent adverse effects (Sims et al., 2021)

Paeonol alleviates ulcerative colitis in mice by increasing short-chain fatty acids derived from Clostridium butyricum

What the Study Found Researchers reviewed 60 anonymous user reports and found: The study concluded that for many users, the benefits of weight loss outweigh short-term discomfort

doi:10.1172/jci.insight.123614 64

their counterparts with obesity or type 2 diabetes without psoriasis

Microbial natural products benefit patients, avoiding injections and acting as alternatives to synthetic drugs and other regular therapies 9